These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35830505)

  • 1. Biomimetic Nanoplatform Loading Type I Aggregation-Induced Emission Photosensitizer and Glutamine Blockade to Regulate Nutrient Partitioning for Enhancing Antitumor Immunotherapy.
    Xie W; Chen B; Wen H; Xiao P; Wang L; Liu W; Wang D; Tang BZ
    ACS Nano; 2022 Jul; 16(7):10742-10753. PubMed ID: 35830505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tumor Environment-Activated Photosensitized Biomimetic Nanoplatform for Precise Photodynamic Immunotherapy of Colon Cancer.
    Xiong M; Zhang Y; Zhang H; Shao Q; Hu Q; Ma J; Wan Y; Guo L; Wan X; Sun H; Yuan Z; Wan H
    Adv Sci (Weinh); 2024 Jul; 11(28):e2402465. PubMed ID: 38728587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.
    Wang M; Wu M; Liu X; Shao S; Huang J; Liu B; Liang T
    Adv Sci (Weinh); 2022 Oct; 9(29):e2202914. PubMed ID: 35981886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication.
    Zhao L; Rao X; Zheng R; Huang C; Kong R; Yu X; Cheng H; Li S
    J Control Release; 2023 May; 357():460-471. PubMed ID: 37068523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necroptosis-Mediated Synergistic Photodynamic and Glutamine-Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for Cholangiocarcinoma.
    Zheng Q; Zou T; Wang W; Zhang C; Hu S; Cheng X; Liu R; Wang G; Sun P; Zhou X; Yang B; Xu J; Gao Y; Gu J
    Adv Sci (Weinh); 2024 Aug; 11(29):e2309203. PubMed ID: 38837691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
    Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors.
    Zhang R; Li R; Zhang L; Chen G; Mo L; Jiang R; Xu X; Wang X; Zhao Y; Zhang L; Wang Y; Zhang B
    ACS Nano; 2023 Jul; 17(14):13461-13473. PubMed ID: 37449998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
    Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
    Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
    Luo J; Wang X; Shi Z; Zeng Y; He L; Cao J; Sun Y; Zhang T; Huang P
    J Nanobiotechnology; 2022 May; 20(1):228. PubMed ID: 35568916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
    Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
    J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
    Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
    Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation-Induced-Emission Photosensitizer-Loaded Nano-Superartificial Dendritic Cells with Directly Presenting Tumor Antigens and Reversed Immunosuppression for Photodynamically Boosted Immunotherapy.
    Sun Z; Liu J; Li Y; Lin X; Chu Y; Wang W; Huang S; Li W; Peng J; Liu C; Cai L; Deng W; Sun C; Deng G
    Adv Mater; 2023 Jan; 35(3):e2208555. PubMed ID: 36255149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reshaping hypoxia and silencing CD73 via biomimetic gelatin nanotherapeutics to boost immunotherapy.
    Yuan CS; Teng Z; Yang S; He Z; Meng LY; Chen XG; Liu Y
    J Control Release; 2022 Nov; 351():255-271. PubMed ID: 36165836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion.
    Leone RD; Zhao L; Englert JM; Sun IM; Oh MH; Sun IH; Arwood ML; Bettencourt IA; Patel CH; Wen J; Tam A; Blosser RL; Prchalova E; Alt J; Rais R; Slusher BS; Powell JD
    Science; 2019 Nov; 366(6468):1013-1021. PubMed ID: 31699883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-programmed nutrient partitioning in the tumour microenvironment.
    Reinfeld BI; Madden MZ; Wolf MM; Chytil A; Bader JE; Patterson AR; Sugiura A; Cohen AS; Ali A; Do BT; Muir A; Lewis CA; Hongo RA; Young KL; Brown RE; Todd VM; Huffstater T; Abraham A; O'Neil RT; Wilson MH; Xin F; Tantawy MN; Merryman WD; Johnson RW; Williams CS; Mason EF; Mason FM; Beckermann KE; Vander Heiden MG; Manning HC; Rathmell JC; Rathmell WK
    Nature; 2021 May; 593(7858):282-288. PubMed ID: 33828302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.
    Zhou F; Feng B; Yu H; Wang D; Wang T; Ma Y; Wang S; Li Y
    Adv Mater; 2019 Apr; 31(14):e1805888. PubMed ID: 30762908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Light-Activated Nanoplatform through Boosting "Eat Me" Signals for Improved CD47-Blocking Immunotherapy.
    Lu Y; Gong Y; Zhu X; Dong X; Zhu D; Ma G
    Adv Healthc Mater; 2022 May; 11(10):e2102712. PubMed ID: 34981660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.